Saturday, 26. September 2026 · Next update: 22:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
💻 Technology · Next Month

Nobel Prize in Chemistry 2026 awarded to David R. Liu (Harvard University) for base editing and prime editing

Pending ✦ AI-generated prediction Published on 26. September 2026 · Predicted for 7. October 2026 · Based on: Speculative
Probability
27%

David R. Liu (Harvard University) is the frontrunner according to the 2026 Clarivate Citation Laureates – for developing base editing and prime editing, precise DNA-repair tools that build on the CRISPR platform and hold broad therapeutic promise for hereditary diseases. Liu received the 2025 Breakthrough Prize for this work. Other strong candidates: Harry Gray & Jay Winkler (Caltech, electron transfer in proteins) and Allara/Nuzzo/Sagiv (self-assembled monolayers). No Polymarket/Kalshi market found for the Chemistry prize; the 27% probability is based on Clarivate's track record (~89 subsequent Nobel laureates from ~500 nominees since 2002), ACS C&EN expert polls, and breadth of the candidate field. Announcement: October 7, 2026, 11:45 CEST, Royal Swedish Academy of Sciences.

Data basis for this prediction
  • Clarivate Citation Laureates 2026: David R. Liu (Harvard) für Base/Prime Editing als Top-Kandidat (chemistryworld.com, 2026)
  • ACS C&EN Experten-Umfrage Nobelpreis Chemie 2026 (cen.acs.org, September 2026)
  • Breakthrough Prize 2025: David R. Liu für Base- und Prime-Editing (Breakthrough Prize Foundation)
  • Bekanntgabedatum Nobelpreis Chemie: 7. Oktober 2026, 11:45 CEST (nobelprize.org Pressemitteilung)
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
Related Predictions
💻 Technology ✦ AI

Meta Platforms (NASDAQ: META) reports total revenue above $62.0 billion in the Q3 FY2026 earnings report (approx. October 29, 2026, confirmed by Meta Investor Relations or Bloomberg by October 30, 2026)

Meta reported Q2 2026 total revenue of $60.80bn (+28% YoY), driven by Family of Apps ad revenue (+27% to $59.4bn), Instagram reaching 2bn daily actives, and Meta AI interactions up 60% (Muse Spark integration). Q3 historically follows a slight positive sequential pattern: in 2024 revenue rose ~+3.8% from Q2 ($39.1bn) to Q3 ($40.6bn). Applying the same ~+3.8% sequential to Q2 2026: 60.80 × 1.038 = ~$63.1bn. The $62.0bn threshold sits just below that. YoY benchmark: Q3 2025 was ~$48.7bn; +27% = $61.8bn, +28% = $62.3bn. Polymarket lists no dedicated Meta Q3 revenue market. Probability ~50% — the threshold sits near the median estimate. Risks: regulation, AI opex escalation, ad market softening. No buy/sell recommendation.

50%
Next Month · Predicted for 29. Oct 2026
💻 Technology ✦ AI

2026 Nobel Prize in Physics awarded to Pablo Jarrillo-Herrero (MIT), H. Allan MacDonald (UT Austin), and Rafi Bistritzer for discovering superconductivity in magic-angle twisted bilayer graphene (announcement October 6, 2026)

Bistritzer & MacDonald predicted in 2011 the twist angle at which bilayer graphene would exhibit exotic quantum properties ('magic angle'). Jarrillo-Herrero's MIT group confirmed this experimentally in 2018, discovering unexpected superconductivity at ~1.1° — launching the field of Moiré quantum materials. Kalshi hosts a Nobel Physics 2026 market; specific odds not retrievable. Among roughly 6–8 serious candidate groups (including Jun Ye & Hidetoshi Katori for optical lattice clocks), Twisted Graphene ranks top 3. Nobel Physics remains structurally hard to predict.

20%
Next Week · Predicted for 6. Oct 2026
💻 Technology ✦ AI

Nobel Prize in Physiology or Medicine 2026 awarded for GLP-1 incretin research (Jens Juul Holst, Svetlana Mojsov and/or Daniel J. Drucker; announcement October 5, 2026)

Jens Juul Holst (University of Copenhagen), Svetlana Mojsov (Rockefeller University) and Daniel J. Drucker (Lunenfeld-Tanenbaum Research Institute, Toronto) were named Clarivate Citation Laureates 2026 on September 17, 2026 for GLP-1 foundational research — the basis for semaglutide (Ozempic/Wegovy) and tirzepatide. Lotte Bjerre Knudsen (Novo Nordisk) is cited as pharmacological complement. GLP-1 is rated the leading candidate field for the 2026 Medicine Nobel by medium.com and oneseventynine.ai. With ~15 competing candidate constellations, single-field probability is approximately 20–25%; no dedicated Polymarket market available.

23%
Next Week · Predicted for 5. Oct 2026